Patents by Inventor Chunmin Jiang

Chunmin Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ZUST49 and bacterial agent, and use thereof
    Patent number: 12599640
    Abstract: The present disclosure discloses a Lactobacillus plantarum ZUST49 and a bacterial agent, and use thereof, and belongs to the technical field of microorganisms. An aspect of the present disclosure provides a Lactobacillus plantarum ZUST49 and a bacterial agent containing the Lactobacillus plantarum ZUST49, and another aspect provides use of the Lactobacillus plantarum ZUST49 and the bacterial agent containing the Lactobacillus plantarum ZUST49. The Lactobacillus plantarum ZUST49 of the present disclosure may convert glucoraphanin into sulforaphane, especially in a human or animal intestinal environment. After an enteric probiotic preparation prepared from the strain of the present disclosure is orally taken, the Lactobacillus plantarum ZUST49 may efficiently convert the glucoraphanin into the sulforaphane in an intestinal tract, which not only solves a problem that stability of the sulforaphane cannot be improved in the prior art, but also effectively exerts a probiotic effect.
    Type: Grant
    Filed: June 20, 2023
    Date of Patent: April 14, 2026
    Assignee: ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Yuanfeng Wu, Chunmin Jiang, Yao Zhang, Ligen Zou, Zisheng Luo, Xinjie Song, Juan Sun, Quanmin Ma, Xuan Zhu, Sabir Z. Nishanbaev
  • LACTOBACILLUS PLANTARUM ZUST49 AND BACTERIAL AGENT, AND USE THEREOF
    Publication number: 20240374661
    Abstract: The present disclosure discloses a Lactobacillus plantarum ZUST49 and a bacterial agent, and use thereof, and belongs to the technical field of microorganisms. An aspect of the present disclosure provides a Lactobacillus plantarum ZUST49 and a bacterial agent containing the Lactobacillus plantarum ZUST49, and another aspect provides use of the Lactobacillus plantarum ZUST49 and the bacterial agent containing the Lactobacillus plantarum ZUST49. The Lactobacillus plantarum ZUST49 of the present disclosure may convert glucoraphanin into sulforaphane, especially in a human or animal intestinal environment. After an enteric probiotic preparation prepared from the strain of the present disclosure is orally taken, the Lactobacillus plantarum ZUST49 may efficiently convert the glucoraphanin into the sulforaphane in an intestinal tract, which not only solves a problem that stability of the sulforaphane cannot be improved in the prior art, but also effectively exerts a probiotic effect.
    Type: Application
    Filed: June 20, 2023
    Publication date: November 14, 2024
    Applicant: ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Yuanfeng Wu, Chunmin Jiang, Yao Zhang, Ligen Zou, Zisheng Luo, Xinjie Song, Juan Sun, Quanmin Ma, Xuan Zhu, Sabir Z. Nishanbaev